There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Most Americans Don’t Know About Medical Aid in Dying Options.
- New NJACTS Publication
- Rutgers’ Mobile Clinic: The Heartbeat of Health for Those Experiencing Homelessness.
- Rutgers Launches Center to Tackle Barriers to Weight Loss and Other Causes of Disease.
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) on 4/24 at 1pm for a Workshop
Categories
- News (2,457)
- Publication (1)